Employment Support After Hematopoietic Stem Cell Transplantation

This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.

Participants will be recruited from MGH Cancer Center. The intervention will be delivered at MGH Institute of Health Professions (IHP) and investigators at MGH IHP will be involved in recruiting participants and collecting/managing data. Participants will be enrolled in the study for approximately six months following the schedule below: * Enrollment into study: HSCT recipients will be recruited into the study approximately six months post HSCT (+/- one month). * Baseline assessment: To be completed within 3 weeks of completing informed consent. * WorkS Appointment #1 and #2: To be completed within a 2-month period after completing the baseline assessment. Ideally, the appointments will be approximately one month apart, but can be timed whenever in the 2-month window that is preferred by the participant. * Exit assessment: To be completed within 3 weeks of completing Appointment 2. * Final assessment: Return to work status at 12 months post HSCT (+/- three weeks)